Business Standard

Friday, February 07, 2025 | 02:51 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Zydus receives USFDA tentative approval for Febuxostat Tablets

Image

Capital Market
Zydus Cadila has received a tentative approval for Febuxostat Tablets (US RLD Uloric), 40 mg and 80 mg. It will be manufactured at the group's formulations manufacturing facility at Moraiya, Ahmedabad. It is used to treat hyperuricemia (constantly high levels of uric acid) in adults who have gout. It helps in decreasing symptoms of gout which include pain, swelling, redness, heat, soreness, and stiffness in certain joints.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Dec 24 2018 | 11:16 AM IST

Explore News